TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sonic Healthcare Limited ( (AU:SHL) ) has issued an update.
Sonic Healthcare Limited announced at its 2025 Annual General Meeting that Dr. Colin Goldschmidt will retire as CEO, with Dr. Jim Newcombe taking over the role. The company also confirmed its earnings guidance for the fiscal year 2026, indicating stability and continuity in its financial performance. This leadership transition and reaffirmation of financial targets suggest a steady strategic direction for the company, potentially reassuring investors and stakeholders about its future prospects.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$23.80 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited is a global healthcare company based in Sydney, Australia, specializing in providing laboratory and radiology services. It operates in the medical diagnostics industry, offering a wide range of pathology and imaging services to medical practitioners, hospitals, and community health services.
Average Trading Volume: 1,710,748
Technical Sentiment Signal: Sell
Current Market Cap: A$10.38B
Learn more about SHL stock on TipRanks’ Stock Analysis page.